Immunohistochemical Analysis of CD99 and PAX8 in a Series of 15 Molecularly Confirmed Cases of Ewing Sarcoma
Open Access
Abstract
Ewing sarcomas are an uncommon group of malignant neoplasms. A multidisciplinary approach is highly recommended to reach a correct diagnosis, considering the clinical, radiological, and histopathological aspects. Since in up to 90% of cases, the translocation t (11; 22) (q24; q12) occurs resulting in a chimeric fusion transcript EWSR1-FLI-1. The pathologist has several tools in addition to conventional techniques (hematoxylin and eosin), such as immunohistochemistry, which plays a very important role in the differential diagnosis. We present a series of 15 cases of molecularly confirmed ES, in which we found a sensitivity of 100% for CD99 and 80% for PAX8 by immunohistochemistry. This indicates a high sensitivity; however, it is known that both CD99 and PAX8 are also expressed in other tumours. Therefore, molecular confirmation should be performed in all cases.Keywords
This publication has 33 references indexed in Scilit:
- The diversity of soft tissue tumours with EWSR1 gene rearrangements: a reviewHistopathology, 2013
- From the Radiologic Pathology Archives: Ewing Sarcoma Family of Tumors: Radiologic-Pathologic CorrelationRadioGraphics, 2013
- Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology - a systematic reviewBMC Veterinary Research, 2013
- Issues in modern bone histomorphometryBone, 2011
- Expression of PAX8 in Normal and Neoplastic TissuesApplied Immunohistochemistry & Molecular Morphology, 2011
- A Comprehensive Analysis of PAX8 Expression in Human Epithelial TumorsAmerican Journal of Surgical Pathology, 2011
- Histological heterogeneity of Ewing’s sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical supportVirchows Archiv, 2009
- Should molecular testing be required for diagnosing synovial sarcoma?Cancer, 2003
- Monophasic Fibrous and Poorly Differentiated Synovial SarcomaAmerican Journal of Surgical Pathology, 2002
- Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumoursNature, 1992